Upstream Bio (UPB) Accounts Payables (2023 - 2025)
Historic Accounts Payables for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $4.0 million.
- Upstream Bio's Accounts Payables fell 1933.05% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 1933.05%. This contributed to the annual value of $4.0 million for FY2024, which is 10306.53% up from last year.
- As of Q3 2025, Upstream Bio's Accounts Payables stood at $4.0 million, which was down 1933.05% from $2.6 million recorded in Q2 2025.
- In the past 5 years, Upstream Bio's Accounts Payables registered a high of $4.9 million during Q3 2024, and its lowest value of $2.0 million during Q4 2023.
- Its 3-year average for Accounts Payables is $3.7 million, with a median of $4.0 million in 2024.
- Per our database at Business Quant, Upstream Bio's Accounts Payables surged by 10306.53% in 2024 and then tumbled by 1933.05% in 2025.
- Upstream Bio's Accounts Payables (Quarter) stood at $2.0 million in 2023, then surged by 103.07% to $4.0 million in 2024, then dropped by 2.2% to $4.0 million in 2025.
- Its Accounts Payables was $4.0 million in Q3 2025, compared to $2.6 million in Q2 2025 and $4.7 million in Q1 2025.